| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.39 | 0.62 | -36.67 |
| EPS, GAAP | 0.66 | 0.97 | 0.97 |
| Consensus Estimate | 0.76 | 0.41 | 86.06 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 5.53 | 3.01 | 83.89 |
| EPS, GAAP | 3.50 | 0.98 | 256.84 |
| Consensus Estimate | 3.60 | 1.16 | 210.34 |
| CLMT | Industry Average | |
| P/E (TTM) | 11.26 | NA |
| P/E (Forward) | 11.42 | NA |
| PEG Ratio | 0.71 | 1.63 |
| Price/Sales | 0.45 | 1.66 |
| Beta | 0.17 | 1.64 |
| 4/10/2013 | North Dakota Undergoes Refining Renaissance (WSJ.com) |
| 3/26/2013 | Stocks to Watch: Ziopharm, Gordmans Stores, Calumet (WSJ.com) |
| 3/26/2013 | MLPs Raise Mountains of Capital (BWP, CLMT, CMLP, DPM, EPB, EROC, EPD, EXLP, HEP, HFC, LRE, MEMP, MCEP, CPNO, KMP, KYN) (24/7 Wall St) |
